AMGN
Amgen Inc
406.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -80.5% | +28.1% | +256.9% | +45.2% | +33.6% | -70.8% | +63.9% | +105.4% | -65.8% | +36.6% | +82.8% | – | |
| – | +54.2% | +1.4% | +0.1% | -0.3% | +0.1% | -0.7% | -3.3% | -2.5% | -13.4% | -1.4% | -200.0% | – | |
| – | – | -78.2% | +52.4% | -13.4% | -1.5% | -36.6% | +84.7% | -19.1% | -1.6% | -40.0% | -200.0% | – | |
| – | -1,794.3% | – | – | +601.6% | +142.9% | -148.9% | – | – | -212.2% | – | – | – | |
| – | +0.4% | -7.6% | +3.5% | +8.0% | +44.4% | +10.8% | -10.2% | +18.2% | +47.2% | +10.9% | -27.9% | – | |
| – | +10,239.3% | -99.2% | +0.0% | -3.2% | +91.4% | +11.2% | -13.0% | +6.4% | +67.4% | +3.3% | -20.5% | – | |
| – | +0.0% | +6.0% | +0.1% | +0.1% | -0.4% | +6.1% | +0.1% | +0.2% | +0.1% | +5.8% | +0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | -60.0% | +50.0% | -100.0% | – | -100.0% | – | |
| – | – | -162.0% | +55.1% | +37.8% | -61.5% | +191.9% | -34.9% | +6.7% | -57.0% | – | -203.2% | – | |
| – | -4,927.0% | – | – | – | – | -206.8% | – | – | -122.3% | – | -32.9% | – | |
| – | -89.5% | +58.8% | +383.9% | +49.2% | +32.8% | -77.7% | +95.0% | +122.3% | -77.4% | +53.7% | +136.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.